Related Experiment Video
Updated: Apr 25, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Does off-pump coronary artery bypass confer any advantage in patients with end-stage renal failure? A systematic
Ju Yong Lim1, Salil V Deo2, Sung Ho Jung1
1Asan Medical Center, Seoul, South Korea.
Insights
For patients with end-stage renal disease undergoing coronary artery bypass grafting, off-pump (OPCABG) and on-pump (ONCABG) surgeries show similar clinical outcomes and mid-term survival. This meta-analysis found no significant advantage for OPCABG in this specific patient group.
Area of Science:
- Cardiovascular Surgery
- Nephrology
- Clinical Outcomes Research
Background:
- Patients with end-stage renal disease (ESRD) are often excluded from clinical trials comparing coronary artery bypass grafting (CABG) techniques.
- Limited data exists on the comparative safety and efficacy of off-pump CABG (OPCABG) versus on-pump CABG (ONCABG) in ESRD patients.
Purpose of the Study:
- To compare adverse clinical events and outcomes between OPCABG and ONCABG in dialysis-dependent patients with ESRD.
- To synthesize existing evidence from retrospective studies to inform surgical decision-making for this vulnerable population.
Main Methods:
- A systematic literature search of PubMed, Scopus, and Web of Science was conducted from inception to June 2013.
- A random-effects inverse variance weighted meta-analysis was performed on data from ten retrospective studies.
- Results were reported as risk ratios (RR) with 95% confidence intervals, with statistical significance set at p<0.05.
Main Results:
- Early mortality was comparable between OPCABG (8.4%) and ONCABG (10.4%) [RR 0.80(0.51-1.17); p=0.35].
- Rates of re-exploration for bleeding and blood transfusion were similar for both surgical approaches.
- While off-pump surgery led to earlier extubation, other post-operative events like stroke and atrial fibrillation, as well as mid-term survival, were comparable.
Conclusions:
- Coronary artery bypass grafting in ESRD patients yields comparable results regardless of whether the procedure is performed off-pump or on-pump.
- Despite the limitations of available retrospective data, this meta-analysis did not identify a significant benefit of OPCABG over ONCABG in this patient cohort.
Objectives:
Patients with end-stage renal disease (ESRD) are often excluded from trials comparing off and on-pump coronary artery bypass grafting (CABG). Thus data in this cohort is limited to small retrospective studies. Hence we compared the adverse clinical events and outcome in patients with ESRD undergoing off (OPCABG) and on-pump surgery (ONCABG).
Methods:
Pubmed, Scopus and Web of Science were searched (inception - June 2013) to identify studies comparing clinical results of OPCABG and ONCABG in dialysis dependent patients. A random effect inverse variance weighted meta-analysis was conducted. Results are presented as risk ratios (RR) with 95% confidence intervals; p<0.05 is significant.
Result:
Ten retrospective studies (2762 OPCABG and 11310 ONCABG) fulfilled criteria and were pooled. Patients undergoing off-pump surgery were less than 100 in most of the articles. Early mortality [OPCABG (8.4%); ONCABG (10.4%)] was comparable [RR 0.80(0.51-1.17); p=0.35; I(2)=30%]. Re-exploration for bleeding [RR 0.81(0.47-1.39); p=0.44] and blood transfusion [RR 0.79(0.57-1.08); p=0.14] were also comparable. While patients undergoing off-pump surgery were extubated earlier (p<0.01), other post-operative events like stroke (p=0.34) and atrial fibrillation (p=0.10) were similar. Mid-term survival (three to five years) was also comparable.
Conclusion:
Patients with end-stage renal disease undergoing coronary artery bypass grafting demonstrate comparable results irrespective of method. While available data is limited to retrospective studies, we failed to demonstrate any significant advantage for performing OPCABG in this group of patients.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Continuous Renal Replacement Therapy
Hemodialysis II: Procedure and Complications

